{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:13:25Z","timestamp":1793229205321,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["CFI-JELF 38412"],"award-info":[{"award-number":["CFI-JELF 38412"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101080249"],"award-info":[{"award-number":["101080249"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["101079417"],"award-info":[{"award-number":["101079417"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs Program","doi-asserted-by":"publisher","award":["950\\u2013232,279"],"award-info":[{"award-number":["950\\u2013232,279"]}],"id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["LA\/P\/0140\/2020"],"award-info":[{"award-number":["LA\/P\/0140\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDP\/04378\/2020"],"award-info":[{"award-number":["UIDP\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Foundation for Science and Technology","doi-asserted-by":"publisher","award":["UIDB\/04378\/2020"],"award-info":[{"award-number":["UIDB\/04378\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["OR2\\u2013189333"],"award-info":[{"award-number":["OR2\\u2013189333"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN-167281"],"award-info":[{"award-number":["FDN-167281"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["EJPRD\/0001\/2020\/B2"],"award-info":[{"award-number":["EJPRD\/0001\/2020\/B2"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007601","name":"Horizon 2020","doi-asserted-by":"publisher","award":["N 825575"],"award-info":[{"award-number":["N 825575"]}],"id":[{"id":"10.13039\/501100007601","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015402","name":"Canada Research Coordinating Committee","doi-asserted-by":"publisher","award":["NFRFG-2022-00033"],"award-info":[{"award-number":["NFRFG-2022-00033"]}],"id":[{"id":"10.13039\/100015402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010785","name":"Canada First Research Excellence Fund","doi-asserted-by":"publisher","award":["CFREF-2022-00007"],"award-info":[{"award-number":["CFREF-2022-00007"]}],"id":[{"id":"10.13039\/501100010785","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ymgme.2025.109075","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T12:03:39Z","timestamp":1741003419000},"page":"109075","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Beyond sialylation: Exploring the multifaceted role of GNE in GNE myopathy"],"prefix":"10.1016","volume":"144","author":[{"given":"Beatriz L.","family":"Pereira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Granjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanns","family":"Lochm\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula A.","family":"Videira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymgme.2025.109075_bb0005","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/7377504","article-title":"Estimating the prevalence of GNE myopathy using population genetic databases","volume":"2024","author":"Derksen","year":"2024","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ymgme.2025.109075_bb0010","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00262-024-03863-7","article-title":"New insights into the immunomodulatory potential of sialic acid on monocyte-derived dendritic cells","volume":"74","author":"Silva","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.ymgme.2025.109075_bb0015","article-title":"The role of sialoglycans in modulating dendritic cell function and tumour immunity","volume":"74\u201375","author":"Silva","year":"2024","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0020","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.3390\/ijms19051304","article-title":"CDG therapies: from bench to bedside","volume":"19","author":"Brasil","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ymgme.2025.109075_bb0025","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.nmd.2017.11.001","article-title":"Phenotypic stratification and genotype\u2013phenotype correlation in a heterogeneous, international cohort of GNE myopathy patients: first report from the GNE myopathy disease monitoring program, registry portion","volume":"28","author":"Pogoryelova","year":"2018","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109075_bb0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/CND.0000000000000181","article-title":"Characterization of strength and function in ambulatory adults with GNE myopathy","volume":"19","author":"Argov","year":"2017","journal-title":"J. Clin. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0035","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3988\/jcn.2019.15.3.275","article-title":"Progression of GNE myopathy based on the patient-reported outcome","volume":"15","author":"Park","year":"2019","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0040","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.3390\/genes13111991","article-title":"Genetic and clinical Spectrum of GNE myopathy in Russia","volume":"13","author":"Murtazina","year":"2022","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.ymgme.2025.109075_bb0045","first-page":"107","article-title":"GNE myopathy: a personal trip from bedside observation to therapeutic trials","volume":"33","author":"Argov","year":"2014","journal-title":"Acta Myol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0050","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2217\/cer-2017-0062","article-title":"Development and preliminary evidence of the psychometric properties of the GNE myopathy functional activity scale","volume":"7","author":"Mayhew","year":"2018","journal-title":"J. Comp. Eff. Res."},{"key":"10.1016\/j.ymgme.2025.109075_bb0055","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173261","article-title":"Substantial deficiency of free sialic acid in muscles of patients with GNE myopathy and in a mouse model","volume":"12","author":"Chan","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2025.109075_bb0060","doi-asserted-by":"crossref","first-page":"e798","DOI":"10.1212\/WNL.0000000000011231","article-title":"Skeletal muscle magnetic resonance biomarkers in GNE myopathy","volume":"96","author":"Liu","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2025.109075_bb0065","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/mus.27451","article-title":"Assessment of thrombocytopenia, sleep apnea, and cardiac involvement in GNE myopathy patients","volume":"65","author":"Mori-Yoshimura","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2025.109075_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.107057","article-title":"Extra-muscular manifestations in GNE myopathy patients: a nationwide repository questionnaire survey in Japan","volume":"212","author":"Yoshioka","year":"2022","journal-title":"Clin. Neurol. Neurosurg."},{"key":"10.1016\/j.ymgme.2025.109075_bb0075","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1055\/s-0038-1649648","article-title":"Influence of platelet membrane sialic acid and platelet-associated IgG on ageing and sequestration of blood platelets in baboons","volume":"70","author":"Kotze","year":"1993","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.ymgme.2025.109075_bb0080","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.5659","article-title":"Novel compound heterozygous mutations in a GNE myopathy with congenital thrombocytopenia: a case report and literature review","volume":"10","author":"Xu","year":"2022","journal-title":"Clin. Case Reports"},{"key":"10.1016\/j.ymgme.2025.109075_bb0085","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/01.HS9.0000565944.96087.88","article-title":"A turkish child presented with neonatal thrombocytopenia associated with GNE mutation without associated muscle wasting","volume":"3","author":"Yilmaz","year":"2019","journal-title":"HemaSphere"},{"key":"10.1016\/j.ymgme.2025.109075_bb0090","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood-2018-04-847798","article-title":"Mutation in GNE is associated with severe congenital thrombocytopenia","volume":"132","author":"Futterer","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ymgme.2025.109075_bb0095","doi-asserted-by":"crossref","DOI":"10.1186\/s12881-020-01163-2","article-title":"Congenital thrombocytopenia associated with GNE mutations in twin sisters: a case report and literature review","volume":"21","author":"Li","year":"2020","journal-title":"BMC Med. Genet."},{"key":"10.1016\/j.ymgme.2025.109075_bb0100","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1007\/s10072-022-05938-8","article-title":"Clinical, genetic, and pathological characterization of GNE myopathy in China","volume":"43","author":"Lv","year":"2022","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.ymgme.2025.109075_bb0105","first-page":"1505","article-title":"Distal myopathy with rimmed vacuoles: Spectrum of GNE gene mutations in seven Chinese patients","volume":"16","author":"Su","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.ymgme.2025.109075_bb0110","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3233\/JND-210629","article-title":"Thigh and leg muscle MRI findings in GNE myopathy","volume":"8","author":"Fatehi","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0115","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1007\/s00415-011-6357-6","article-title":"Muscle imaging findings in GNE myopathy","volume":"259","author":"Tasca","year":"2012","journal-title":"J. Neurol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0120","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/sim.8050","article-title":"Bayesian model of disease progression in GNE myopathy","volume":"38","author":"Quintana","year":"2019","journal-title":"Stat. Med."},{"key":"10.1016\/j.ymgme.2025.109075_bb0125","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1080\/09638288.2017.1283712","article-title":"Patient reported outcomes in GNE myopathy: incorporating a valid assessment of physical function in a rare disease","volume":"40","author":"Slota","year":"2018","journal-title":"Disabil. Rehabil."},{"key":"10.1016\/j.ymgme.2025.109075_bb0130","article-title":"Unfolded protein response and activated degradative pathways regulation in GNE myopathy","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2025.109075_bb0135","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1471-4159.2007.05208.x","article-title":"Hyposialylation of neprilysin possibly affects its expression and enzymatic activity in hereditary inclusion-body myopathy muscle","volume":"105","author":"Broccolini","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ymgme.2025.109075_bb0140","doi-asserted-by":"crossref","first-page":"942","DOI":"10.3389\/fneur.2018.00942","article-title":"GNE myopathy with novel mutations and pronounced Paraspinal muscle atrophy","volume":"9","author":"Soule","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0145","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1002\/mus.26486","article-title":"Clinical utility of RNA sequencing to resolve unusual GNE myopathy with a novel promoter deletion","volume":"60","author":"Chakravorty","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2025.109075_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2018.01.002","article-title":"Discordant manifestations in Italian brothers with GNE myopathy","volume":"386","author":"Dotti","year":"2018","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.ymgme.2025.109075_bb0155","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.nmd.2016.11.007","article-title":"Granuloma formation in a patient with GNE myopathy: a case report","volume":"27","author":"Nakamura","year":"2017","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109075_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjno-2022-000362","article-title":"Long-term evaluation parameters in GNE myopathy: a 5-year observational follow-up natural history study","volume":"4","author":"Mori-Yoshimura","year":"2022","journal-title":"BMJ Neurol. Open"},{"key":"10.1016\/j.ymgme.2025.109075_bb0165","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.nmd.2013.06.426","article-title":"GNE myopathy functional activity scale (GNEM-FAS): development of a disease-specific instrument for measuring function and independence","volume":"23","author":"Skrinar","year":"2013","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109075_bb0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3233\/JND-200565","article-title":"Results from a 3-year non-interventional, observational disease monitoring program in adults with GNE myopathy","volume":"8","author":"Lochm\u00fcller","year":"2021","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0175","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10974-020-09590-7","article-title":"Tissue specific expression of sialic acid metabolic pathway: role in GNE myopathy","volume":"42","author":"Awasthi","year":"2021","journal-title":"J. Muscle Res. Cell Motil."},{"key":"10.1016\/j.ymgme.2025.109075_bb0180","doi-asserted-by":"crossref","first-page":"5267","DOI":"10.1073\/pnas.072066199","article-title":"Sialylation is essential for early development in mice","volume":"99","author":"Schwarzkopf","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ymgme.2025.109075_bb0185","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13023-018-0802-x","article-title":"GNE myopathy: from clinics and genetics to pathology and research strategies","volume":"13","author":"Pogoryelova","year":"2018","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0190","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/j.nmd.2023.08.013","article-title":"GNE myopathy: can homozygous asymptomatic subjects give a clue for the identification of protective factors?","volume":"33","author":"Mitrani-Rosenbaum","year":"2023","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109075_bb0195","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/jhg.2016.134","article-title":"Missing genetic variations in GNE myopathy: rearrangement hotspots encompassing 5\u2019UTR and founder allele","volume":"62","author":"Zhu","year":"2017","journal-title":"J. Hum. Genet."},{"key":"10.1016\/j.ymgme.2025.109075_bb0200","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.nmd.2021.12.007","article-title":"Upper body involvement in GNE myopathy assessed by muscle imaging","volume":"32","author":"Torchia","year":"2022","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109075_bb0205","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1002\/mgg3.300","article-title":"Identification of an Alu element-mediated deletion in the promoter region of GNE in siblings with GNE myopathy","volume":"5","author":"Garland","year":"2017","journal-title":"Mol. Genet. Genomic Med."},{"key":"10.1016\/j.ymgme.2025.109075_bb0210","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000000308","article-title":"GNE genotype explains 20% of phenotypic variability in GNE myopathy","volume":"5","author":"Pogoryelova","year":"2019","journal-title":"Neurol. Genet."},{"key":"10.1016\/j.ymgme.2025.109075_bb0215","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/jnnp-2013-306414","article-title":"Mutation analysis of a large cohort of GNE myopathy reveals a diverse array of GNE mutations affecting sialic acid biosynthesis","volume":"85","author":"Ohno","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.ymgme.2025.109075_bb0220","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.biochi.2022.03.014","article-title":"Functional characterization of GNE mutations prevalent in Asian subjects with GNE myopathy, an ultra-rare neuromuscular disorder","volume":"199","author":"Sharma","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.ymgme.2025.109075_bb0225","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1002\/mus.26337","article-title":"GNE myopathy in the bedouin population of Kuwait: genetics, prevalence, and clinical description","volume":"58","author":"Alrohaif","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2025.109075_bb0230","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000494115","article-title":"Population-based prevalence study of genetic muscle disorders","volume":"52","author":"Theadom","year":"2019","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.ymgme.2025.109075_bb0235","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1186\/s13023-020-01487-5","article-title":"Pregnancy in GNE myopathy patients: a nationwide repository survey in Japan","volume":"15","author":"Yoshioka","year":"2020","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0240","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.bbagen.2019.05.011","article-title":"Activity of N-acylneuraminate-9-phosphatase (NANP) is not essential for de novo sialic acid biosynthesis","volume":"1863","author":"Willems","year":"2019","journal-title":"Biochim. Biophys. Acta, Gen. Subj."},{"key":"10.1016\/j.ymgme.2025.109075_bb0245","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1515\/BC.2001.036","article-title":"Biosynthesis of N-acetylneuraminic acid in cells lacking UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase","volume":"382","author":"Hinderlich","year":"2001","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109075_bb0250","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1212\/01.wnl.0000200956.76449.3f","article-title":"NCAM is hyposialylated in hereditary inclusion body myopathy due to GNE mutations","volume":"66","author":"Ricci","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2025.109075_bb0255","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ymgme.2003.11.012","article-title":"Hypoglycosylation of alpha-dystroglycan in patients with hereditary IBM due to GNE mutations","volume":"81","author":"Huizing","year":"2004","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109075_bb0260","series-title":"Essentials Glycobiol","article-title":"Antibodies and Lectins in Glycan Analysis","author":"Cummings","year":"2009"},{"key":"10.1016\/j.ymgme.2025.109075_bb0265","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/mus.26135","article-title":"Quantification of lectin fluorescence in GNE myopathy muscle biopsies","volume":"58","author":"Leoyklang","year":"2018","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymgme.2025.109075_bb0270","doi-asserted-by":"crossref","first-page":"27016","DOI":"10.1074\/jbc.M604903200","article-title":"Roles for UDP-GlcNAc 2-epimerase\/ManNAc 6-kinase outside of sialic acid biosynthesis: modulation of sialyltransferase and BiP expression, GM3 and GD3 biosynthesis, proliferation, and apoptosis, and ERK1\/2 phosphorylation","volume":"281","author":"Wang","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109075_bb0275","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.gep.2017.03.003","article-title":"The expression of sialyltransferases is regulated by the bioavailability and biosynthesis of sialic acids","volume":"23\u201324","author":"Bork","year":"2017","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.ymgme.2025.109075_bb0280","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.nmd.2020.05.008","article-title":"The glycomic sialylation profile of GNE myopathy muscle cells does not point to consistent hyposialylation of individual glycoconjugates","volume":"30","author":"Sela","year":"2020","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109075_bb0285","doi-asserted-by":"crossref","first-page":"9637","DOI":"10.1074\/jbc.M116.764597","article-title":"Effects of altered sialic acid biosynthesis on N-linked glycan branching and cell surface interactions","volume":"292","author":"Pham","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109075_bb0290","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1093\/glycob\/cwj063","article-title":"Complex N-glycans are the major ligands for galectin-1, \u22123, and \u22128 on Chinese hamster ovary cells","volume":"16","author":"Patnaik","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.ymgme.2025.109075_bb0295","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1634\/stemcells.2005-0564","article-title":"Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration","volume":"24","author":"Chan","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.ymgme.2025.109075_bb0300","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/dvdy.21123","article-title":"Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration","volume":"236","author":"Georgiadis","year":"2007","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.ymgme.2025.109075_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016334","article-title":"The proteomic profile of hereditary inclusion body myopathy","volume":"6","author":"Sela","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2025.109075_bb0310","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3233\/JND-190461","article-title":"Upregulation of Hallmark muscle genes protects GneM743T\/M743T mutated Knock-in mice from kidney and muscle phenotype","volume":"7","author":"Benyamini","year":"2020","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0315","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0002477","article-title":"UDP-N-acetylglucosamine-2-epimerase\/N-acetylmannosamine kinase (GNE) binds to alpha-actinin 1: novel pathways in skeletal muscle?","volume":"3","author":"Amsili","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.ymgme.2025.109075_bb0320","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1007\/s12035-016-9862-x","article-title":"The interaction of UDP-N-Acetylglucosamine 2-epimerase\/N-Acetylmannosamine kinase (GNE) and alpha-Actinin 2 is altered in GNE myopathy M743T mutant","volume":"54","author":"Harazi","year":"2017","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0325","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1016\/j.febslet.2006.11.015","article-title":"The collapsin response mediator protein 1 (CRMP-1) and the promyelocytic leukemia zinc finger protein (PLZF) bind to UDP-N-acetylglucosamine 2-epimerase\/N-acetylmannosamine kinase (GNE), the key enzyme of sialic acid biosynthesis","volume":"580","author":"Weidemann","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2025.109075_bb0330","doi-asserted-by":"crossref","first-page":"6316","DOI":"10.1007\/s12035-021-02549-w","article-title":"Generation and characterization of a skeletal muscle cell-based model carrying one single Gne allele: implications in actin dynamics","volume":"58","author":"Devi","year":"2021","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0335","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s12017-022-08711-4","article-title":"Effect of GNE mutations on cytoskeletal network proteins: potential gateway to understand Pathomechanism of GNEM","volume":"24","author":"Yadav","year":"2022","journal-title":"NeuroMolecular Med."},{"key":"10.1016\/j.ymgme.2025.109075_bb0340","article-title":"Altered actin dynamics in cell migration of GNE mutant cells., front. Cell","volume":"9","author":"Devi","year":"2021","journal-title":"Dev. Biol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0345","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1016\/j.febslet.2007.04.062","article-title":"Sialic acid is an essential moiety of mucin as a hydroxyl radical scavenger","volume":"581","author":"Ogasawara","year":"2007","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2025.109075_bb0350","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0014-5793(04)00164-4","article-title":"Novel biological function of sialic acid (N-acetylneuraminic acid) as a hydrogen peroxide scavenger","volume":"561","author":"Iijima","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ymgme.2025.109075_bb0355","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111092","article-title":"Sialic acid associated with oxidative stress and total antioxidant capacity (TAC) expression level as a predictive indicator in moderate to severe Alzheimer\u2019s disease","volume":"141","author":"Yadav","year":"2020","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0360","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s13340-019-00395-9","article-title":"The correlation between blood oxidative stress and sialic acid content in diabetic patients with nephropathy, hypertension, and hyperlipidemia","volume":"11","author":"Shahvali","year":"2020","journal-title":"Diabetol. Int."},{"key":"10.1016\/j.ymgme.2025.109075_bb0365","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/hmg\/ddx192","article-title":"Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy","volume":"26","author":"Cho","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2025.109075_bb0370","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1002\/jcb.30148","article-title":"Elucidation of ER stress and UPR pathway in sialic acid-deficient cells: pathological relevance to GNEM","volume":"122","author":"Chaudhary","year":"2021","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.ymgme.2025.109075_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2022.106258","article-title":"Role of HSP70 chaperone in protein aggregate phenomenon of GNE mutant cells: therapeutic lead for GNE myopathy","volume":"149","author":"Yadav","year":"2022","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0380","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41536-022-00238-3","article-title":"Myogenesis defects in a patient-derived iPSC model of hereditary GNE myopathy","volume":"7","author":"Schmitt","year":"2022","journal-title":"Npj Regen. Med."},{"key":"10.1016\/j.ymgme.2025.109075_bb0385","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1093\/hmg\/ddm220","article-title":"A GNE knockout mouse expressing human GNE D176V mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy","volume":"16","author":"Malicdan","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2025.109075_bb0390","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1093\/hmg\/ddl446","article-title":"A Gne knockout mouse expressing human V572L mutation develops features similar to distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy","volume":"16","author":"Malicdan","year":"2007","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2025.109075_bb0395","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1074\/jbc.M111.297051","article-title":"Peracetylated N-acetylmannosamine, a synthetic sugar molecule, efficiently rescues muscle phenotype and biochemical defects in mouse model of sialic acid-deficient myopathy","volume":"287","author":"Malicdan","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ymgme.2025.109075_bb0400","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2022.930110","article-title":"In vivo and in vitro genome editing to explore GNE functions","volume":"4","author":"Ilouz","year":"2022","journal-title":"Front. Genome Ed."},{"key":"10.1016\/j.ymgme.2025.109075_bb0405","doi-asserted-by":"crossref","first-page":"6116","DOI":"10.1038\/s41467-023-41769-7","article-title":"Fast, multiplexable and efficient somatic gene deletions in adult mouse skeletal muscle fibers using AAV-CRISPR\/Cas9","volume":"14","author":"Th\u00fcrkauf","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ymgme.2025.109075_bb0410","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.cell.2014.09.014","article-title":"CRISPR-Cas9 knockin mice for genome editing and cancer modeling","volume":"159","author":"Platt","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.ymgme.2025.109075_bb0415","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1093\/hmg\/ddu045","article-title":"Gne depletion during zebrafish development impairs skeletal muscle structure and function","volume":"23","author":"Daya","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ymgme.2025.109075_bb0420","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.976111","article-title":"Generation and characterization of a novel gne knockout model in zebrafish","volume":"10","author":"Livne","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0425","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2377-7-3","article-title":"Intravenous immune globulin in hereditary inclusion body myopathy: a pilot study","volume":"7","author":"Sparks","year":"2007","journal-title":"BMC Neurol."},{"key":"10.1016\/j.ymgme.2025.109075_bb0430","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3233\/JND-159900","article-title":"Aceneuramic acid extended release administration maintains upper limb muscle strength in a 48-week study of subjects with GNE myopathy: results from a phase 2, randomized, controlled study","volume":"3","author":"Argov","year":"2016","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0435","doi-asserted-by":"crossref","first-page":"e2109","DOI":"10.1212\/WNL.0000000000006932","article-title":"A phase 3 randomized study evaluating sialic acid extended-release for GNE myopathy","volume":"92","author":"Lochm\u00fcller","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.ymgme.2025.109075_bb0440","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3233\/JND-230029","article-title":"Phase II\/III study of aceneuramic acid administration for GNE myopathy in Japan","volume":"10","author":"Suzuki","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0445","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13023-023-02850-y","article-title":"Efficacy confirmation study of aceneuramic acid administration for GNE myopathy in Japan","volume":"18","author":"Mori-Yoshimura","year":"2023","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0450","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.ymgme.2017.04.010","article-title":"Safety, pharmacokinetics and sialic acid production after oral administration of N-acetylmannosamine (ManNAc) to subjects with GNE myopathy","volume":"122","author":"Xu","year":"2017","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.ymgme.2025.109075_bb0455","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1038\/s41436-021-01259-x","article-title":"Safety and efficacy of N-acetylmannosamine (ManNAc) in patients with GNE myopathy: an open-label phase 2 study","volume":"23","author":"Carrillo","year":"2021","journal-title":"Genet. Med."},{"key":"10.1016\/j.ymgme.2025.109075_bb0460","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/brain\/awu210","article-title":"Sialyllactose ameliorates myopathic phenotypes in symptomatic GNE myopathy model mice","volume":"137","author":"Yonekawa","year":"2014","journal-title":"Brain"},{"key":"10.1016\/j.ymgme.2025.109075_bb0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115689","article-title":"Pharmacokinetics and clinical efficacy of 6\u2032-sialyllactose in patients with GNE myopathy: randomized pilot trial","volume":"168","author":"Park","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymgme.2025.109075_bb0470","doi-asserted-by":"crossref","first-page":"8178","DOI":"10.1021\/acs.jmedchem.9b00833","article-title":"Targeting GNE myopathy: a dual prodrug approach for the delivery of N-Acetylmannosamine 6-phosphate","volume":"62","author":"Morozzi","year":"2019","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ymgme.2025.109075_bb0475","doi-asserted-by":"crossref","DOI":"10.1002\/cpz1.500","article-title":"Synthesis of 2-Acetamido-1,3,4-tri-O-Acetyl-2-deoxy-D-Mannopyranose \u22126-phosphate prodrugs as potential therapeutic agents","volume":"2","author":"Pertusati","year":"2022","journal-title":"Curr. Protoc."},{"key":"10.1016\/j.ymgme.2025.109075_bb0480","doi-asserted-by":"crossref","first-page":"179","DOI":"10.3233\/JND-210755","article-title":"Pre clinical assessment of AAVrh74.MCK.GNE viral vector therapeutic potential: robust activity despite lack of consistent animal model for GNE","volume":"9","author":"Mitrani-Rosenbaum","year":"2022","journal-title":"Myopathy., J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.114958","article-title":"Metformin protects fibroblasts from patients with GNE myopathy by restoring autophagic flux via an AMPK\/mTOR-independent pathway","volume":"164","author":"Zhang","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ymgme.2025.109075_bb0490","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/j.nmd.2012.03.013","article-title":"Sustained expression and safety of human GNE in normal mice after gene transfer based on AAV8 systemic delivery","volume":"22","author":"Mitrani-Rosenbaum","year":"2012","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymgme.2025.109075_bb0495","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3233\/JND-221596","article-title":"Development of assays to measure GNE gene potency and gene replacement in skeletal muscle","volume":"10","author":"Zygmunt","year":"2023","journal-title":"J. Neuromuscul. Dis."},{"key":"10.1016\/j.ymgme.2025.109075_bb0500","doi-asserted-by":"crossref","first-page":"978","DOI":"10.3390\/genes10120978","article-title":"Artificial intelligence (AI) in rare diseases: is the future brighter?","volume":"10","author":"Brasil","year":"2019","journal-title":"Genes (Basel)"}],"container-title":["Molecular Genetics and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096719225000666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T12:48:57Z","timestamp":1778590137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096719225000666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S1096719225000666"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109075","relation":{},"ISSN":["1096-7192"],"issn-type":[{"value":"1096-7192","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Beyond sialylation: Exploring the multifaceted role of GNE in GNE myopathy","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgme.2025.109075","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109075"}}